Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × ofatumumab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 26 Leukemia, B-Cell 10 Lymphoma 7 Leukemia 7 Recurrence 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Neoplasms 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Waldenstrom Macroglobulinemia 3 Burkitt Lymphoma 3 Thrombocytopenia 1 Paraproteinemias 1 Oncology Patients Receiving Chemotherapy 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphocytosis 1 Lymphadenopathy 1 Leukemia, Prolymphocytic 1 Leukemia, Lymphoid 1 Fever 1 Fatigue 1 Bronchiolitis Obliterans Syndrome 1 Agammaglobulinemia 1

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡